Revenue
2022
2023
2024
2025
2026
Medinotec Inc. (MDNC)
Price$5.00Cached quote
Net income
2022
2023
2024
2025
2026
Free cash flow
2022
2023
2024
2025
2026
Total cash / debt
CashTotal debt
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $9.7M | $9.1M | $5.0M | $999,579 | $1.0M |
| Gross profit | $5.1M | $4.8M | $2.4M | $581,822 | $455,154 |
| Gross margin | 52.71% | 52.87% | 48.65% | 58.21% | 43.75% |
| Research & development | $149,858 | $91,133 | $22,351 | $64,866 | $34,767 |
| Operating expenses | $4.0M | $1.6M | $1.8M | $820,409 | $645,770 |
| Operating income | $1.1M | $3.2M | $600,578 | −$238,587 | −$190,616 |
| Operating margin | 11.25% | 35.02% | 11.96% | −23.87% | −18.32% |
| EBITDA | $1.2M | $3.3M | $688,803 | −$185,034 | −$107,807 |
| EBITDA margin | 12.08% | 35.83% | 13.72% | −18.51% | −10.36% |
| Net income | $794,502 | $2.2M | −$404,688 | −$352,735 | −$123,999 |
| Net profit margin | 8.17% | 23.70% | −8.06% | −35.29% | −11.92% |
| Basic EPSper basic share | $0.07 | $0.18 | -$0.03 | -$0.03 | $0.01 |
| Diluted EPSper diluted share | $0.07 | $0.18 | -$0.03 | -$0.03 | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Vizirgianakis Stavros G. | 4.75M |
Vizirgianakis Gregory | 4.75M |
van Niekerk Pieter Mohr | 401.97K |
SPIRAKIS ATHANASIOS | 12.07K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 3 ↗Updated Sep 29, 2026 · Quarterly data